Search Results for: Alzheimer

3183 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
APOE and PCMT1 apolipoprotein E protein-L-isoaspartate (D-aspartate) O-methyltransferase
  • Lipoprotein metabolism
  • Metabolism of lipids and lipoproteins
  • Chylomicron-mediated lipid transport
  • Lipid digestion, mobilization, and transport
  • Diseases associated with visual transduction
  • HDL-mediated lipid transport
  • Visual phototransduction
  • Scavenging by Class A Receptors
  • Retinoid metabolism and transport
  • Human Serum Albumin
  • Serum albumin iodonated
  • S-Adenosyl-L-Homocysteine
APOE and RHEB apolipoprotein E Ras homolog enriched in brain
  • Lipoprotein metabolism
  • Metabolism of lipids and lipoproteins
  • Chylomicron-mediated lipid transport
  • Lipid digestion, mobilization, and transport
  • Diseases associated with visual transduction
  • HDL-mediated lipid transport
  • Visual phototransduction
  • Scavenging by Class A Receptors
  • Retinoid metabolism and transport
  • Insulin receptor signalling cascade
  • IRS-mediated signalling
  • Regulation of Rheb GTPase activity by AMPK
  • mTOR signalling
  • S6K1-mediated signalling
  • IRS-related events
  • mTOR signalling
  • Release of eIF4E
  • mTORC1-mediated signalling
  • IGF1R signaling cascade
  • S6K1-mediated signalling
  • mTORC1-mediated signalling
  • IRS-related events triggered by IGF1R
  • IRS-mediated signalling
  • Release of eIF4E
  • Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
  • Energy dependent regulation of mTOR by LKB1-AMPK
  • PKB-mediated events
  • PI3K Cascade
  • PKB-mediated events
  • PI3K Cascade
  • Signaling by Insulin receptor
  • Human Serum Albumin
  • Serum albumin iodonated
APOE and LRP8 apolipoprotein E low density lipoprotein receptor-related protein 8, apolipoprotein e receptor
  • Lipoprotein metabolism
  • Metabolism of lipids and lipoproteins
  • Chylomicron-mediated lipid transport
  • Lipid digestion, mobilization, and transport
  • Diseases associated with visual transduction
  • HDL-mediated lipid transport
  • Visual phototransduction
  • Scavenging by Class A Receptors
  • Retinoid metabolism and transport
  • Visual phototransduction
  • Platelet homeostasis
  • Platelet sensitization by LDL
  • Diseases associated with visual transduction
  • Retinoid metabolism and transport
  • Human Serum Albumin
  • Serum albumin iodonated
BCL2L1 and PSEN1 BCL2-like 1 presenilin 1
  • Inflammasomes
  • The NLRP1 inflammasome
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • Programmed Cell Death
  • BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members
  • Innate Immune System
  • Intrinsic Pathway for Apoptosis
  • Degradation of the extracellular matrix
CACNA1A and HECW1 calcium channel, voltage-dependent, P/Q type, alpha 1A subunit HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1
  • Integration of energy metabolism
  • Regulation of insulin secretion
  • Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels
  • Transmission across Chemical Synapses
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • TCF dependent signaling in response to WNT
  • RNF mutants show enhanced WNT signaling and proliferation
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • degradation of DVL
  • Signaling by Wnt
  • Signaling by WNT in cancer
  • Pregabalin
  • Verapamil
  • Loperamide
  • Bepridil
CACNA1A and RIMBP2 calcium channel, voltage-dependent, P/Q type, alpha 1A subunit RIMS binding protein 2
  • Integration of energy metabolism
  • Regulation of insulin secretion
  • Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels
  • Transmission across Chemical Synapses
  • Pregabalin
  • Verapamil
  • Loperamide
  • Bepridil
CASP1 and PSEN1 caspase 1, apoptosis-related cysteine peptidase presenilin 1
  • Signaling by Interleukins
  • The NLRP3 inflammasome
  • Inflammasomes
  • NOD1/2 Signaling Pathway
  • The AIM2 inflammasome
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • Interleukin-1 processing
  • The IPAF inflammasome
  • Cytokine Signaling in Immune system
  • Innate Immune System
  • Degradation of the extracellular matrix
  • Minocycline
  • 1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE
  • 3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO-PENTANOIC ACID
  • 3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRI ACID
CASP3 and PSEN1 caspase 3, apoptosis-related cysteine peptidase presenilin 1
  • SMAC binds to IAPs
  • SMAC-mediated dissociation of IAP:caspase complexes
  • SMAC-mediated apoptotic response
  • Cytochrome c-mediated apoptotic response
  • Caspase-mediated cleavage of cytoskeletal proteins
  • Degradation of the extracellular matrix
  • Role of DCC in regulating apoptosis
  • Activation of caspases through apoptosome-mediated cleavage
  • Activation of DNA fragmentation factor
  • Apoptotic factor-mediated response
  • Programmed Cell Death
  • Intrinsic Pathway for Apoptosis
  • Signalling by NGF
  • Apoptotic cleavage of cellular proteins
  • Cell death signalling via NRAGE, NRIF and NADE
  • Apoptotic execution phase
  • p75 NTR receptor-mediated signalling
  • Stimulation of the cell death response by PAK-2p34
  • Apoptotic cleavage of cell adhesion proteins
  • Signaling by Hippo
  • Apoptosis induced DNA fragmentation
  • Extrinsic Pathway
  • NADE modulates death signalling
  • Degradation of the extracellular matrix
  • Minocycline
  • 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid
  • 2-HYDROXY-5-(2-MERCAPTO-ETHYLSULFAMOYL)-BENZOIC ACID
  • methyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxopentanoate
  • 1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE
  • [N-(3-DIBENZYLCARBAMOYL-OXIRANECARBONYL)-HYDRAZINO]-ACETIC ACID
  • 4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID
  • (1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate
  • (1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate
  • N-[3-(2-fluoroethoxy)phenyl]-N\'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide
CASP4 and PSEN1 caspase 4, apoptosis-related cysteine peptidase presenilin 1
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • NOD1/2 Signaling Pathway
  • Innate Immune System
  • Degradation of the extracellular matrix
CASP6 and PSEN1 caspase 6, apoptosis-related cysteine peptidase presenilin 1
  • Apoptotic cleavage of cellular proteins
  • Programmed Cell Death
  • Apoptotic execution phase
  • Breakdown of the nuclear lamina
  • Caspase-mediated cleavage of cytoskeletal proteins
  • Degradation of the extracellular matrix
CASP7 and PSEN1 caspase 7, apoptosis-related cysteine peptidase presenilin 1
  • Activation of caspases through apoptosome-mediated cleavage
  • Apoptotic cleavage of cellular proteins
  • Apoptotic factor-mediated response
  • SMAC binds to IAPs
  • Apoptotic execution phase
  • Programmed Cell Death
  • SMAC-mediated dissociation of IAP:caspase complexes
  • Cytochrome c-mediated apoptotic response
  • SMAC-mediated apoptotic response
  • Caspase-mediated cleavage of cytoskeletal proteins
  • Intrinsic Pathway for Apoptosis
  • Degradation of the extracellular matrix
  • Fica
CDK5 and PSEN1 cyclin-dependent kinase 5 presenilin 1
  • Signaling by GPCR
  • Axon guidance
  • Semaphorin interactions
  • Opioid Signalling
  • DARPP-32 events
  • CRMPs in Sema3A signaling
  • Factors involved in megakaryocyte development and platelet production
  • Degradation of the extracellular matrix
  • Indirubin-3\'-Monoxime
  • Olomoucine
  • Hymenialdisine
  • SU9516
  • Flavopiridol
  • Alsterpaullone
  • 6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE
CFL1 and PSEN1 cofilin 1 (non-muscle) presenilin 1
  • Axon guidance
  • Semaphorin interactions
  • Platelet degranulation
  • EPHB-mediated forward signaling
  • Response to elevated platelet cytosolic Ca2+
  • Sema3A PAK dependent Axon repulsion
  • EPH-Ephrin signaling
  • Platelet activation, signaling and aggregation
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • Regulation of actin dynamics for phagocytic cup formation
  • Innate Immune System
  • Degradation of the extracellular matrix
CFTR and SLC4A8 cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) solute carrier family 4, sodium bicarbonate cotransporter, member 8
  • ABC-family proteins mediated transport
  • Transport of inorganic cations/anions and amino acids/oligopeptides
  • SLC-mediated transmembrane transport
  • Bicarbonate transporters
  • Bumetanide
  • Glyburide
  • Ibuprofen
  • Adenosine-5\'-Diphosphate
  • Phosphoaminophosphonic Acid-Adenylate Ester
  • Phosphonoserine
  • Crofelemer
  • Ivacaftor
CLU and VHL clusterin von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
  • Response to elevated platelet cytosolic Ca2+
  • Platelet degranulation
  • Platelet activation, signaling and aggregation
  • Cellular response to hypoxia
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Regulation of Hypoxia-inducible Factor (HIF) by oxygen
  • Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
  • Class I MHC mediated antigen processing & presentation
  • Adaptive Immune System
CLU and TGFBR2 clusterin transforming growth factor, beta receptor II (70/80kDa)
  • Response to elevated platelet cytosolic Ca2+
  • Platelet degranulation
  • Platelet activation, signaling and aggregation
  • Loss of Function of TGFBR2 in Cancer
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • Loss of Function of SMAD2/3 in Cancer
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Downregulation of TGF-beta receptor signaling
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • Loss of Function of SMAD4 in Cancer
  • TGFBR1 KD Mutants in Cancer
  • TGF-beta receptor signaling activates SMADs
  • TGFBR1 LBD Mutants in Cancer
  • Loss of Function of TGFBR1 in Cancer
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Signaling by TGF-beta Receptor Complex
  • SMAD4 MH2 Domain Mutants in Cancer
  • Glycerol
COL4A1 and DISC1 collagen, type IV, alpha 1 disrupted in schizophrenia 1
  • Signaling by PDGF
  • NCAM1 interactions
  • Collagen formation
  • Axon guidance
  • Collagen degradation
  • Anchoring fibril formation
  • Non-integrin membrane-ECM interactions
  • Degradation of the extracellular matrix
  • Assembly of collagen fibrils and other multimeric structures
  • Laminin interactions
  • ECM proteoglycans
  • Integrin cell surface interactions
  • Collagen biosynthesis and modifying enzymes
  • NCAM signaling for neurite out-growth
  • Scavenging by Class A Receptors
CTNNA1 and PSEN1 catenin (cadherin-associated protein), alpha 1, 102kDa presenilin 1
  • Cell junction organization
  • Cell-cell junction organization
  • CDO in myogenesis
  • Myogenesis
  • Signaling by VEGF
  • Adherens junctions interactions
  • VEGFR2 mediated vascular permeability
  • VEGFA-VEGFR2 Pathway
  • Degradation of the extracellular matrix
CTNND1 and PSEN1 catenin (cadherin-associated protein), delta 1 presenilin 1
  • Cell junction organization
  • Cell-cell junction organization
  • Signaling by VEGF
  • Adherens junctions interactions
  • VEGFR2 mediated vascular permeability
  • VEGFA-VEGFR2 Pathway
  • Degradation of the extracellular matrix
CYP2C8 and PSEN1 cytochrome P450, family 2, subfamily C, polypeptide 8 presenilin 1
  • Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B)
  • Metabolism of lipids and lipoproteins
  • Metabolic disorders of biological oxidation enzymes
  • Phase 1 - Functionalization of compounds
  • Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A)
  • Arachidonic acid metabolism
  • Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4)
  • Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)
  • Cytochrome P450 - arranged by substrate type
  • CYP2E1 reactions
  • Biological oxidations
  • Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD)
  • Defective FMO3 causes Trimethylaminuria (TMAU)
  • Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)
  • Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)
  • Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX)
  • Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4)
  • Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA)
  • Defective CYP1B1 causes Glaucoma
  • Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5)
  • Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3)
  • Defective CYP19A1 causes Aromatase excess syndrome (AEXS)
  • Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)
  • Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)
  • Xenobiotics
  • Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)
  • Defective MAOA causes Brunner syndrome (BRUNS)
  • Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency)
  • Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3)
  • Degradation of the extracellular matrix

Page 7 out of 160 pages